Literature DB >> 15318097

Comparative analyses of four different methods of genotyping ALDH2.

Sakae Itoga1, Toru Nanmoku, Takayuki Uchimoto, Masahiko Sunaga, Masahiko Nezu, Takeshi Tomonaga, Shoji Harada, Fumio Nomura.   

Abstract

BACKGROUND: A number of methods of genotyping single nucleotide polymorphisms (SNPs) are currently available, ranging from the traditional restriction fragment length polymorphism (RFLP) and single-stranded conformational polymorphism (SSCP) to more sophisticated technologies. We determined the utility of three novel methods by genotyping aldehyde dehydrogenase-2 (ALDH2).
METHODS: DNA was isolated from blood samples of 241 control subjects and 74 patients with esophageal cancer. The utility of three novel genotyping methods-melting curve analysis using a LightCycler, SNaPshot analysis using an ABI PRISM 310 genetic analyzer, and denaturing high-performance liquid chromatography using a WAVE DNA fragment analysis system-were compared with that of conventional fluorescent-based polymerase chain reaction (PCR)-SSCP using an ALF express DNA sequencer.
RESULTS: The frequency of the mutant ALDH2*2 allele was significantly higher in patients with esophageal cancer (27.7%) than in control subjects (16.2%; p < 0.01; habitual alcohol drinkers). The melting curve analysis was accurate, more rapid, and easier to use than the SNaPshot analysis or denaturing high-performance liquid chromatography analysis. Fluorescent-based PCR-SSCP proved useful for analyzing a large number of samples.
CONCLUSION: Melting curve analysis using the LightCycler is suitable for the genotyping of small numbers of samples in a routine clinical setting; fluorescent-based PCR-SSCP analysis using the ALF express DNA sequencer can be used for large-scale genotyping in epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15318097     DOI: 10.1097/01.alc.0000133585.65144.61

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  3 in total

1.  Relationship between genetic polymorphisms of ALDH2 and ADH1B and esophageal cancer risk: a meta-analysis.

Authors:  Shu-Juan Yang; Akira Yokoyama; Tetsuji Yokoyama; Yu-Chuan Huang; Si-Ying Wu; Ying Shao; Jin Niu; Jie Wang; Yu Liu; Xiao-Qiao Zhou; Chun-Xia Yang
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

2.  Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer: evidence from 31 case-control studies.

Authors:  Tingting Zhao; Chun Wang; Lili Shen; Dongying Gu; Zhi Xu; Xunlei Zhang; Yong Xu; Jinfei Chen
Journal:  Onco Targets Ther       Date:  2015-03-23       Impact factor: 4.147

3.  Genotyping on ALDH2: comparison of four different technologies.

Authors:  Lina Zhang; Jinzhao Zhao; Guanglin Cui; Hong Wang; Dao Wen Wang
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.